Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug

ISSN: 1875-6417 (Online)
ISSN: 1573-3998 (Print)


Volume 10, 6 Issues, 2014


Download PDF Flyer




Current Diabetes Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Norman E. Cameron
University of Aberdeen
Aberdeen, Scotland
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug

Author(s): Nida Akhtar

Affiliation: H. No. 1559, near Old P.O. Pakbara, Moradabad-244001, Uttar Pradesh, India.

Abstract

Diabetes Mellitus is a chronic metabolic disease affecting wide range of people across the globe. In India the rate of subjects being suffered from diabetes is continuously increasing. So, the development of drugs for its effective treatment is essential. Thereby, various attempts have been made to discover newer drugs, to reduce the rate of anti diabetic occurrence. Anti-diabetic drugs were found to treat diabetes mellitus by lowering glucose levels in the blood. Both the use antidiabetic drugs as well as the changes in lifestyle and proper diet can significantly affect the severity of diabetes mellitus and also reduces the symptoms and occurrence of the disease. Researches in the past few years on diabetes mellitus showed that this disease is spreading at a very faster rate, thereby; various attempts have been made to treat it efficaciously. Development and approval of antidiabetic drugs is quite necessary. There are different classes of anti-diabetic drugs reported to treat diabetes. The objective of the present review is to explore Invokana as a newly approved antidiabetic drug for the effective treatment of type 2 diabetes. This review focuses mainly on the various aspects of diabetes mellitus and its treatment perspectives. From the various clinical studies done on Invokana, it was concluded that and Invokana was found to be very effective for the efficacious therapy of diabetes mellitus.

Keywords: Diabetes, glucose, hypoglycaemic, insulin, metabolism, obesity.

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 9
Issue Number: 6
First Page: 478
Last Page: 490
Page Count: 13
DOI: 10.2174/15733998113096660085
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science